Analyst Ratings for Alnylam Pharmaceuticals (ALNY)
ALNY Rating Summary
ALNY Price Target Summary
- Highest: $225.00 (H.C. Wainwright)
- Lowest: $90.00 (SVB Leerink)
- Average: $167.79
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$167.79 (+1.7%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 61%
Avg. $ Target:
$167.79 (+1.7%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 61%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/22/2021 | Guggenheim | Whitney Ljem | Downgrade | Neutral (Buy) |
N/A (N/A) |
155.06 (165.02) |
6.42% | Details |
| 2/12/2021 | Citi | Joel Beatty | Downgrade | Neutral (Buy) |
175.00 (170.00) |
165.38 (165.02) |
-0.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
